Pol JG - Search Results

1

Development and applications of oncolytic Maraba virus vaccines.

Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD. Pol JG, et al. Oncolytic Virother. 2018 Nov 26;7:117-128. doi: 10.2147/OV.S154494. eCollection 2018. Oncolytic Virother. 2018. PMID: 30538968 Free PMC article. Review.

2

HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.

Bridle BW, Chen L, Lemay CG, Diallo JS, Pol J, Nguyen A, Capretta A, He R, Bramson JL, Bell JC, Lichty BD, Wan Y. Bridle BW, et al. Mol Ther. 2013 Apr;21(4):887-94. doi: 10.1038/mt.2012.265. Epub 2013 Jan 8. Mol Ther. 2013. PMID: 23295947 Free PMC article.

3

Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses.

Zhang L, Bridle BW, Chen L, Pol J, Spaner D, Boudreau JE, Rosen A, Bassett JD, Lichty BD, Bramson JL, Wan Y. Zhang L, et al. Blood. 2013 Mar 28;121(13):2432-9. doi: 10.1182/blood-2012-06-438481. Epub 2013 Jan 16. Blood. 2013. PMID: 23325836 Free article.

4

[Genetic, immunological, and pharmacological strategies to generate improved oncolytic viruses].

Pol J, Le Bœuf F, Diallo JS. Pol J, et al. Med Sci (Paris). 2013 Feb;29(2):165-73. doi: 10.1051/medsci/2013292014. Epub 2013 Feb 28. Med Sci (Paris). 2013. PMID: 23452603 Free article. Review. French.

5

Panorama from the oncolytic virotherapy summit.

Pol JG, Marguerie M, Arulanandam R, Bell JC, Lichty BD. Pol JG, et al. Mol Ther. 2013 Oct;21(10):1814-8. doi: 10.1038/mt.2013.207. Mol Ther. 2013. PMID: 24081122 Free PMC article. No abstract available.

6

Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8⁺ T-cell responses to anticancer vaccines.

Bridle BW, Clouthier D, Zhang L, Pol J, Chen L, Lichty BD, Bramson JL, Wan Y. Bridle BW, et al. Oncoimmunology. 2013 Aug 1;2(8):e26013. doi: 10.4161/onci.26013. Epub 2013 Aug 27. Oncoimmunology. 2013. PMID: 24083086 Free PMC article.

7

Maraba virus as a potent oncolytic vaccine vector.

Pol JG, Zhang L, Bridle BW, Stephenson KB, Rességuier J, Hanson S, Chen L, Kazdhan N, Bramson JL, Stojdl DF, Wan Y, Lichty BD. Pol JG, et al. Mol Ther. 2014 Feb;22(2):420-429. doi: 10.1038/mt.2013.249. Epub 2013 Oct 25. Mol Ther. 2014. PMID: 24322333 Free PMC article.

8

Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.

Workenhe ST, Simmons G, Pol JG, Lichty BD, Halford WP, Mossman KL. Workenhe ST, et al. Among authors: pol jg. Mol Ther. 2014 Jan;22(1):123-31. doi: 10.1038/mt.2013.238. Epub 2013 Oct 9. Mol Ther. 2014. PMID: 24343053 Free PMC article.

9

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.

Workenhe ST, Pol JG, Lichty BD, Cummings DT, Mossman KL. Workenhe ST, et al. Among authors: pol jg. Cancer Immunol Res. 2013 Nov;1(5):309-19. doi: 10.1158/2326-6066.CIR-13-0059-T. Epub 2013 Aug 19. Cancer Immunol Res. 2013. PMID: 24777969

10

S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3.

Wang F, Alain T, Szretter KJ, Stephenson K, Pol JG, Atherton MJ, Hoang HD, Fonseca BD, Zakaria C, Chen L, Rangwala Z, Hesch A, Chan ESY, Tuinman C, Suthar MS, Jiang Z, Ashkar AA, Thomas G, Kozma SC, Gale M Jr, Fitzgerald KA, Diamond MS, Mossman K, Sonenberg N, Wan Y, Lichty BD. Wang F, et al. Among authors: pol jg. Nat Immunol. 2016 May;17(5):514-522. doi: 10.1038/ni.3433. Epub 2016 Apr 4. Nat Immunol. 2016. PMID: 27043414 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page